~~<i id='3C810A9BC1'><strike id='3C810A9BC1'><tt id='3C810A9BC1'><pre id='3C810A9BC1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

comprehensive

author：hotspot 2025-09-27 12:56:37 - browse：874

Stoke Therapeutics is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy, following the release of updated data Tuesday that showed disappointing reductions in convulsive seizure activity.

In the latest look at an ongoing mid-stage study, three monthly injections of the Stoke drug, called STK-001, given at a 45-mg dose, resulted in a median 18% reduction in convulsive seizure activity, compared to baseline.

The new analysis was conducted on 16 children diagnosed with a rare form of epilepsy called Dravet syndrome. Last November, in six patients, the drug showed a median 55% reduction in seizure activity.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Florida Supreme Court upholds state's abortion ban

explore

hotspot

explore

knowledge

hotspot

SuhasGondiofBrighamandWomen'sHospitalhasresearchedandwrittenabouthospitalboardsincreasinglybeingmade

WSS

Insurer loopholes limit power of law against surprise medical bills

Gilgo Beach: Police identify another victim in serial killing investigation

Verily hires former Apple Health leader as chief scientific officer

OTC birth control: A brief history of over the counter pill design

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

hotspot

comprehensive

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Humana, CVS hope to turn members into patients at clinics

Hepatitis C has a cure — but many Americans still lack access to it

What the cancer research community can learn from the Covid response

United colonoscopy coverage change 'may cost lives,' doctors say

Microsoft strikes partnership with Duke Health to advance health AI

Continuity nursing helped my family in our darkest PICU moments

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Trump demands the U.S. pay no more for drugs than other countries … again

Nearly two

explore

Bird flu in dairy cattle: New measures to control spread to humans

What Henrietta Lacks settlement says about racism in medicine

Mass General Brigham physicians react to latest merger step

Young boy dies in trial for Pfizer Duchenne gene therapy

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Influencer to be charged after chaos erupts in New York City's Union Square

hotspot

explore

knowledge

hotspot